Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.850
-0.010 (-0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
1.877
+0.027 (1.47%)
After-hours: Apr 28, 2026, 6:12 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $226.90 million as of April 28, 2026. Its market cap has increased by 356.56% in one year.
Market Cap
226.90M
Enterprise Value
181.16M
1-Year Change
356.56%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $226.90M, a decrease of -37.57%. That is a compound annual growth rate of -6.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |
| Camp4 Therapeutics | 230.52M |
| Polaryx Therapeutics | 229.61M |
| Keros Therapeutics | 226.95M |